TOBAM’s Pediatrix Medical MD Stock Holding History

TOBAM’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-1,260	Closed	-$67K	–	178
2017 Q4	$67K	Sell	1,260 -130,657	-99%	-$6.16M	﹤0.01%	160
2017 Q3	$5.69M	Buy	+131,917	New	+$6.27M	0.21%	88

Other funds holding MD

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BHG

Blue Harbour Group Greenwich, Connecticut $353M AUM 8.9% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return

Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

TOBAM's MD Position: Q1 2018 in Review

TOBAM sold out of Pediatrix Medical (MD) in Q1 2018, closing a stake of 1,260 shares — an estimated $67K sold.

TOBAM first reported a position in MD in Q3 2017 and held it in 2 quarters. The position peaked at $5.69M in Q3 2017. 342 funds tracked by Wall St. Rank hold MD as of Q1 2018.

TOBAM reported no remaining Pediatrix Medical position as of Q1 2018 after selling out during the quarter.
TOBAM sold 1,260 Pediatrix Medical shares in Q1 2018, an estimated $67K.
TOBAM first reported a position in Pediatrix Medical in Q3 2017 and held it in 2 quarters.
TOBAM's Pediatrix Medical position peaked at $5.69M in Q3 2017.
342 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2018.

Based on TOBAM's 13F filing for Q1 2018, filed 14 May 2018.